Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: kukuiokala who wrote (393)	1/27/1999 11:25:00 PM
From: Ron Sirch	Read Replies (1) \| Respond to of 471

Conference call was very upbeat, including the Q and A portion. In addition to reviewing the Q2 numbers, Skip Cummins talked about the momentum that is building very rapidly. December ended strong and has carried over into January...... He read a letter from a patient whose broken life has been restored since her implant. Doctors had totally given up until someone recommended NCP..... The company will not reveal at this point in time what two disorders are the subject of their FDA-sponsored pilot studies but one of them already has shown very encouraging results in patients who have received NCP implants..... A 20% thinner, 27% lighter NCP unit with an extended life of 10 years will be ready in the third quarter..... Objective quarter to quarter growth for Q3 and Q4 is 27%. Profitable by Q4..... Big plans for patient and doctor exposure meetings in Q3. Two big conferences planned for the medical community. All of this to accelerate moving NCP from new miracle last resort therapy to a universally accepted standard therapy of choice...... Seizure reduction rates are coming in significantly better than the results attained during the studies completed in connection with the FDA approval process! Likewise for side benefits such as improved memory and mood elevation. Above should not in any way be considered transcript. There was much more but thought this would give you an idea how it went. Excellent conference call IMO. The future looks bright. Extremely bright.